Profound Medical Corp.: enters co-education agreement with Telix

What happened On Oct 9, 2026, Profound Medical Corp. issued a press release announcing that the Company entered into a co-education agreement with Telix Pharmaceuticals Limited. The press release was furnished as Exhibit 99.1 to the Current Report on Form 8-K.

Key details

• Date of disclosure: Oct 9, 2026.
• Parties: Profound Medical Corp. and Telix Pharmaceuticals Limited.
• The disclosure was made under Item 7.01, Regulation FD Disclosure, and the press release is Exhibit 99.1.
• The report is signed Oct 9, 2026 by Arun Menawat, Chief Executive Officer and Chairman.

Why it may matter The filing reports an Item 7.01 Regulation FD Disclosure, which covers public disclosure of information (here, a press release) about a co-education agreement with Telix Pharmaceuticals Limited. A filing does not show why the insider traded or why the company acted.